About Manisha Chatterjee

Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst. Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.


Recent Articles By Manisha Chatterjee

: SNDR |  News, Ratings, and Charts

3 Transportation Stocks to Buy as Supply Chain Issues Continue

Because the transportation industry plays a significant role in the supply chain systems of several businesses, it is witnessing massive demand amid the current supply chain crisis. And because the forthcoming holiday season is expected to increase the demand for transportation significantly, we think it could be wise to bet on quality transportation stocks Schneider National (SNDR), Daseke (DSKE), and USA Truck (USAK). Read on.
: COIN |  News, Ratings, and Charts

Does Coinbase Deserve a Place in Your Portfolio?

Among other contributing factors, crypto economy-based financial technology company Coinbase’s (COIN) shares have soared in price over the past few months on bitcoin’s price advance. But can the stock continue to gain even in the face of an ongoing investigation into the company? Read on to learn more.
: PBTS |  News, Ratings, and Charts

Is Powerbridge Technologies a Buy Under $2?

China-based software company Powerbridge Technologies (PBTS) has made several developments regarding cryptocurrency mining. However, its shares have retreated in price over the past few months and are currently trading below $2. So, let’s find out if it is wise to bet on the stock now. Read on.
: CRSR |  News, Ratings, and Charts

Should You Buy the Dip in Corsair Gaming?

Even though Corsair Gaming (CRSR) has introduced and upgraded several products over the past few months, the stock has declined in price significantly. So, let’s find out if it is wise to buy the dip in the stock despite the company’s pedestrian financials. Read on
: SCHW |  News, Ratings, and Charts

Charles Schwab is Trading at All-Time Highs, is it Still a Buy?

Impressive third-quarter earnings and increased retail trading helped investment services company Charles Schwab’s (SCHW) shares hit their all-time price high of $81.63 yesterday. But can the stock continue to rally despite an ongoing investigation into the company? Read on, let’s find out.
: CYRN |  News, Ratings, and Charts

Does Penny Stock CYREN Belong in Your Portfolio?

Israel-based cybersecurity company Cyren (CYRN) boasts a broad consumer base and has been completing several product developments with the help of Cyber Inbox Security. However, CYRN’s shares have declined in price over the past few months. So, let’s evaluate if it is wise to scoop up its shares now. Read on.
: LMFA |  News, Ratings, and Charts

Consider Adding LM Funding America to Your Portfolio, Here’s Why

Finance company LM Funding America’s (LMFA) shares have surged with soaring bitcoin prices over the past few months. Moreover, the company reported impressive financials for the second quarter. So read on to learn why it could be wise to add the stock to one’s portfolio now.
: OMF |  News, Ratings, and Charts

5 Reasons Why OneMain Holdings is a Screaming Buy

Financial services company OneMain Holdings (OMF) reported impressive second-quarter results and paid a $4.20 per share dividend in August 2021. Furthermore, we think the stock possesses solid value and growth attributes and, as such, may now be an attractive buy. Read on.
: RBLX |  News, Ratings, and Charts

Is the Pullback in Roblox an Opportunity or Warning Sign?

The recent success of Squid Game helped online entertainment platform operator Roblox (RBLX) grab the market’s attention. However, the company’s stock has declined in price over the past few months as schools have reopened and children have returned to outdoor activities. So, is it wise to buy the stock now, or is there further downside in the offing? Let’s find out.
: MBII |  News, Ratings, and Charts

Should You Buy Marrone Bio Innovations Under $1?

The shares of bio-based pest management and plant health products provider Marrone Bio Innovations’ (MBII) have declined in price over the past few months amid challenging weather conditions and supply chain constraints. So, the question becomes, is it wise to buy the stock now as the company advances three novel bioherbicides? Let’s find out.
Page generated in 0.5234 seconds.